Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tufuling total glycosides tablets in rheumatoid arthritis (phase II)
CTR20171128Phase 2Completed
- Sponsor
- Nanjing University
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of smilax glabra total glycosides in rheumatoid arthritis (RA), sponsored by Nanjing University. Started Dec 2017; status: completed.
02
Drugs
smilax glabra total glycosides
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20171128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171128.